Latest Stories
Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions
Veterinary Cancer Society Annual Conference 2023
Canine Lymphoma Diagnostics Past, Present and Future: How AI technology and genetics are pushing the boundaries in veterinary medicine
Veterinary Cancer Society Annual Conference 2023
Impact of AI on clinical practice and outcome
Veterinary Cancer Society Annual Conference 2023
Identification of drug response biomarkers for canine lymphoma in large-scale NGS screen
Veterinary Cancer Society Annual Conference 2023
ImpriMed: AI-driven Personalized Medicine for Pet Cancer Care
Veterinary Cancer Society-Veterinary Society of Surgical Oncology Collaborative Conference 2023
Reinventing precision medicine: from dogs to humans
Precision Medicine World Conference 2023
Identification of Novel Predictive Biomarkers of Anticancer Drug Responses in Canine B-Cell Lymphoma Using Targeted NGS
Veterinary Cancer Society Annual Conference 2022
Drugs predicted to be effective using artificial intelligence (AI) double the clinical response rate in canines with relapsed B-cell lymphoma
Veterinary Cancer Society Mid-Year Conference 2022
Precision medicine for pet cancer care
Animal Health, Nutrition and Technology Innovation Europe 2022
Predicting dynamic clinical outcomes of (L-)CHOP chemotherapy for canine lymphoma patients using an artificial intelligence model
Veterinary Cancer Society Annual Conference 2021
ImpriMed: Experiences from the eyes of an oncologist in clinical practice
Veterinary Cancer Society Annual Conference 2021
Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model
Veterinary Cancer Society Annual Conference 2020
ImpriMed: A data-driven, personalized chemotherapy drug testing service for canine blood cancer patients
Veterinary Cancer Society Annual Conference 2021
Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test
World Veterinary Cancer Congress 2020
From dog to human: precision medicine for comparative oncology
Precision Medicine World Conference 2020